Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics Europe 2024

Martyn Boutelle's Biography

Martyn Boutelle, Professor of Biomedical Sensors Engineering, Imperial College London

Martyn Boutelle is Professor of Biomedical Sensors Engineering in the Department of Bioengineering, Imperial College London, and Associate Provost for Estates Planning for Imperial College.
His research group is multidisciplinary comprising, bioengineers, scientists, and clinicians. He develops novel analytical science methods using microfluidics, electrochemical sensors / biosensors, and wireless electronics to make portable (sometimes wearable) monitoring devices for use as point of care devices that typically giving continuous real -time displays. He then uses these in a program of clinical science research focusing on the acute traumatic brain injury including that caused by cardiac arrest, neonatal continuous monitoring and kidney transplantation monitoring. He runs the EPSRC funded Bio-nanofabrication suite designed to make microfluidic and biosensor biosensors using scalable methods to allow use in proof-of-concept clinical trials.

Martyn is past president of the International Society for Monitoring Molecules in Neuroscience, and a founder of the COSBID organization for studying acute human brain injury. He published > 190 papers, chapters and patents. He obtained a BSc and PhD in Chemistry from Imperial College and worked as an EP Abraham Research Fellow in the University of Oxford.

Martyn Boutelle Image

Real-Time Point-of-Care Diagnostics Using Microfluidic Sensors and Biosensors

Monday, 24 June 2024 at 12:00

Add to Calendar ▼2024-06-24 12:00:002024-06-24 13:00:00Europe/LondonReal-Time Point-of-Care Diagnostics Using Microfluidic Sensors and BiosensorsLab-on-a-Chip and Microfluidics Europe 2024 in Rotterdam, The NetherlandsRotterdam, The

We are investigating technologies that take POC measurements from a moment in time that assists diagnosis to a continuous information stream that guides treatment dynamically. Biomarker molecule concentrations can give important information about the health of a person as they are dynamically challenged by acute illness or for example during clinical treatment. Such an approach would allow individualized treatments to be chosen and optimized. We have been developing a range of sensing and biosensing solutions for the invasive, minimally invasive, and non-invasive monitoring of people in healthcare situations. Microfluidics provide a valuable means of clinical sampling and robust quantification of measured signals.

I will describe the key challenges in the development of such integrated sensing devices and present our recent data obtained during models of cardiac arrest and from the neonatal intensive care unit.

Add to Calendar ▼2024-06-24 00:00:002024-06-25 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics Europe 2024Lab-on-a-Chip and Microfluidics Europe 2024 in Rotterdam, The NetherlandsRotterdam, The